Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetanus immunoglobulin
- Development stage
- Unknown
- Lead developer
- Kedrion
- Modality
- Antibody-Based Therapeutics
- Administration
- Intramuscular
01
Overview
IG-Tet (also known as Ig Tetano) is a human tetanus immunoglobulin preparation containing high titers of antibodies (mainly IgG) against the tetanus toxin produced by *Clostridium tetani*. It is used for passive immunization to provide immediate, short-term protection against tetanus. The primary indications include post-exposure prophylaxis after tetanus-prone injuries in individuals who are unvaccinated, incompletely vaccinated, or whose immunization status is uncertain, as well as the treatment of clinically manifest tetanus. IG-Tet is administered via intramuscular injection and works by binding to and neutralizing unbound tetanus toxin, preventing it from entering the nervous system and causing severe muscle spasms or autonomic dysfunction. The product is manufactured by Kedrion and distributed in the Philippines by New Marketlink Pharmaceutical.
- Brand names
- IG-Tet
- Other names
- HTIGTIGhuman tetanus immune globulinhuman tetanus immunoglobulintetanus antitoxin (human)tetanus immune globulintetanus immune globulin (human)tetanus immunoglobulintetanus immunoglobulin (human)tetanus immunoglobulin, human
Beyond the preview
Go deeper on tetanus immunoglobulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetanus immunoglobulin.